Early Use of Glucocorticoids Was a Risk Factor for Critical Disease and Death From pH1N1 Infection

医学 风险因素 疾病 病毒学 重症监护医学 免疫学 内科学
作者
Ke Han,Hong Ma,X. An,Ying Su,J Chen,Zhichao Lian,J. Zhao,Bao‐Ping Zhu,Robert E. Fontaine,Zheng Feng,Guang Zeng
出处
期刊:Clinical Infectious Diseases [Oxford University Press]
卷期号:53 (4): 326-333 被引量:101
标识
DOI:10.1093/cid/cir398
摘要

Background. Glucocorticoids increase the risk of developing critical disease from viral infections. However, primary care practitioners in China use them as antipyretics, potentially exposing hundreds of millions to this risk. Methods. We enrolled all patients with confirmed pandemic influenza A (pH1N1) virus infection aged ≥3 years with available medical records at 4 Shenyang City hospitals from 20 October to 30 November 2009. A critical patient was any confirmed, hospitalized pH1N1 patient who developed ≥1 of the following: death, respiratory failure, septic shock, failure or insufficiency of ≥2 nonpulmonary organs, mechanical ventilation, or ICU admission. In a retrospective cohort study, we evaluated the risk of developing critical illness in relation to early (≤72 hours of influenza-like illness [ILI] onset) glucocorticoids treatment. Results. Of the 83 hospitalized case-patients, 46% developed critical illness, 17% died, and 37% recovered and were discharged. Critically ill and other patients did not differ by underlying conditions and severity, median temperature at first clinic visit, and other measured risk factors. Of 17 patients who received early glucocorticoid treatment, 71% subsequently developed critical disease compared with 39% of 66 patients who received late (>72 hours) or no glucocorticoid treatment (RRM-H = 1.8, 95% CI = 1.2–2.8, after adjusting for 2 summary variables; ie, presence of underlying diseases and presence of underlying risk factors). Proportional hazards modeling showed that use of glucocorticoids tripled the hazard of developing critical disease (hazard ratio [HR] = 2.9, 95% CI = 1.3–6.2, after adjusting for the same summary variables). Conclusions. Early use of parenteral glucocorticoids therapy for fever reduction and pneumonia prevention increases the risk for critical disease or death from pH1N1 infection. We recommend that guidelines on glucocorticoid use be established and enforced.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
MMCC应助CC采纳,获得10
1秒前
危机的毛衣完成签到,获得积分10
2秒前
顾灵毓完成签到,获得积分10
2秒前
希望天下0贩的0应助chinwen采纳,获得10
2秒前
琴power完成签到,获得积分10
2秒前
nianshu完成签到 ,获得积分0
3秒前
3秒前
小果完成签到 ,获得积分10
3秒前
复杂的从菡完成签到,获得积分10
3秒前
酷炫的星星完成签到,获得积分10
4秒前
nnl发布了新的文献求助10
4秒前
5秒前
qwer完成签到,获得积分10
5秒前
开心石头完成签到 ,获得积分10
5秒前
充电宝应助www采纳,获得10
6秒前
6秒前
彩色的荔枝完成签到,获得积分10
7秒前
繁星jia完成签到 ,获得积分10
7秒前
独特成威完成签到 ,获得积分10
7秒前
charry完成签到,获得积分10
7秒前
7秒前
传奇3应助zard采纳,获得10
8秒前
火山羊发布了新的文献求助10
9秒前
科研通AI6.3应助旰旰旰采纳,获得10
10秒前
12秒前
完美世界应助Xu乐采纳,获得10
12秒前
dian发布了新的文献求助10
13秒前
木子林夕完成签到,获得积分10
13秒前
13秒前
14秒前
文具盒完成签到,获得积分10
14秒前
所所应助饱满如风采纳,获得10
15秒前
叁壹粑粑完成签到,获得积分10
15秒前
liuzhuohao应助pier采纳,获得10
16秒前
18秒前
可爱的函函应助torch132采纳,获得10
18秒前
orixero应助DrKe采纳,获得20
19秒前
nicole发布了新的文献求助10
20秒前
Kepler发布了新的文献求助10
20秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Development of a Bridge Weigh-In-Motion System: A technology to convert the bridge response to the passage of traffic into data on vehicle configurations, speeds, times of travel and weights 1000
Molecular Mechanisms of Photosynthesis, 4th Edition 1000
Organic Reactions, Volume 116 1000
Current concepts in cutaneous toxicity : proceedings of the Fourth Conference on Cutaneous Toxicity, Washington, D.C., May 9-11, 1979 1000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7264939
求助须知:如何正确求助?哪些是违规求助? 8886072
关于积分的说明 18779738
捐赠科研通 6942736
什么是DOI,文献DOI怎么找? 3202782
关于科研通互助平台的介绍 2375987
邀请新用户注册赠送积分活动 2178699